AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

X4 Pharmaceuticals, Inc Director's Dealing 2020

Oct 6, 2020

34355_dirs_2020-10-06_10eac812-e2ae-4fcc-b346-4eaff9de8eaf.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: X4 Pharmaceuticals, Inc (XFOR)
CIK: 0001501697
Period of Report: 2020-10-05

Reporting Person: Lawton Alison Frances (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10134	Direct